Related references
Note: Only part of the references are listed.Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization
Julie Makani et al.
BLOOD (2010)
The inherited diseases of hemoglobin are an emerging global health burden
David J. Weatherall
BLOOD (2010)
RNAi-based therapeutics-current status, challenges and prospects
Katrin Tiemann et al.
EMBO MOLECULAR MEDICINE (2009)
Developmental and species-divergent globin switching are driven by BCL11A
Vijay G. Sankaran et al.
NATURE (2009)
Direct inhibition of the NOTCH transcription factor complex
Raymond E. Moellering et al.
NATURE (2009)
Common Genetic Variation and Human Traits
David B. Goldstein
NEW ENGLAND JOURNAL OF MEDICINE (2009)
GENE THERAPY β-Thalassemia Treatment Succeeds, With a Caveat
Jocelyn Kaiser
SCIENCE (2009)
Hemoglobin research and the origins of molecular medicine
Alan N. Schechter
BLOOD (2008)
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and Amelioration of the phenotype of β-thalassemia
Manuela Uda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Vijay G. Sankaran et al.
SCIENCE (2008)
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Jacob Hanna et al.
SCIENCE (2007)
The HBS1L-MYB intergenic region on chromosome 6q23.3 influences erythrocyte, platelet, and monocyte counts in humans
Stephan Menzel et al.
BLOOD (2007)
A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Stephan Menzel et al.
NATURE GENETICS (2007)
A method for the covalent capture and screening of diverse small molecules in a microarray format
James E. Bradner et al.
NATURE PROTOCOLS (2006)
Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation
K Stegmaier et al.
NATURE GENETICS (2004)